Alnylam Pharmaceuticals, Inc. (FRA:DUL)
Germany · Delayed Price · Currency is EUR 299.60
-3.90 (-1.29%)
At close: Jan 27, 2026
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of €37.59 billion as of January 30, 2026. Its market cap has increased by 19.47% in one year.
Market Cap
37.59B
Enterprise Value
37.63B
Revenue
2.74B
Ranking
n/a
PE Ratio
1,012.44
Stock Price
€299.60
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 37.59B, an increase of 39,530.00%. That is a compound annual growth rate of 31.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 37.59B | -15.98% |
| Dec 31, 2025 | 44.74B | 52.63% |
| Dec 31, 2024 | 29.32B | 34.90% |
| Dec 29, 2023 | 21.73B | -20.57% |
| Dec 30, 2022 | 27.36B | 53.40% |
| Dec 31, 2021 | 17.83B | 44.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.30M |